MichaelDocktorMD

Clinical Director of Innovation | Director of Clinical Mobile Solutions - Boston Children's Hospital | Harvard Medical School - Co-Founder @DockHealth & @HealthVoyager

Join to view full profile

Dr. Docktor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Docktor's full profile

Already have an account?

Office
300 Longwood Ave
Hunnewell Ground
Boston, MA 02115
Phone+1 617-355-2962

Fax+1 617-730-0494

Summary

I am a pediatric gastroenterologist with a specific interest in Inflammatory Bowel Disease and a passionate techie. I am fascinated by mobility and app development and how it is changing our lives as physicians and our ability to empower and take better care of our patients.

Education & Training

Boston Children’s Hospital//Boston Medical CenterFellowship, Pediatric Gastroenterology, 2011
Children's Hospital Los AngelesResidency, Pediatrics, 2005 - 2008
Children's Hospital Los AngelesInternship, Pediatrics, 2005 - 2006
Rutgers New Jersey Medical SchoolClass of 2005

Certifications & Licensure

CA State Medical License 2007 - Present
MA State Medical License 2008 - 2025
NY State Medical License 2015 - 2021
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Gastroenterology

Publications & Presentations

PubMed

Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease.
Yanjia Jason Zhang, Athos Bousvaros, Michael Docktor, Abby L Kaplan, Paul A Rufo
Scientific Reports. 2024-08-06
1 citations
Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after Fecal Microbiota Transplant in Inflammatory Bowel Disease.
Yanjia Jason Zhang, Athos Bousvaros, Michael Docktor, Abby Kaplan, Paul A Rufo
Medrxiv. 2023-02-01
5 citations
Efficacy and Outcomes of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
Maribeth R Nicholson, Erin Alexander, Sonia Arora Ballal, Zev Davidovics, Michael Docktor
Journal of Crohn's & Colitis. 2021-11-12

Press Mentions

Interview with Dock Health CEO Dr. Michael DocktorMay 27th, 2021
HealthVoyager Selected as Winner of Lilly’s Digital Health Innovation ChallengeDecember 2nd, 2019
Leveraging Consumer Technology in Gastroenterology PracticeAugust 22nd, 2019
Join now to see all

Industry Relationships

Clinical Avisor, UBiome2015 - Present
Clinical Advisor, Leo Health2015 - Present
Clinical Advisor, TigerText